Zacks Research Downgrades Amrize (NYSE:AMRZ) to Strong Sell

Amrize (NYSE:AMRZGet Free Report) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Wednesday,Zacks.com reports.

A number of other analysts also recently issued reports on AMRZ. Sanford C. Bernstein reissued an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Morgan Stanley set a $63.00 price target on Amrize and gave the stock an “overweight” rating in a research note on Monday, June 22nd. Royal Bank Of Canada lowered Amrize from a “sector perform” rating to an “underperform” rating and decreased their price objective for the stock from $60.00 to $48.00 in a report on Monday, August 10th. Finally, Stephens dropped their price objective on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a report on Wednesday, August 12th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Amrize currently has a consensus rating of “Moderate Buy” and a consensus price target of $60.57.

View Our Latest Stock Report on AMRZ

Amrize Stock Performance

NYSE AMRZ opened at $44.64 on Wednesday. Amrize has a 52-week low of $44.30 and a 52-week high of $65.94. The company has a 50-day simple moving average of $50.69 and a 200 day simple moving average of $54.23. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The company has a market capitalization of $24.69 billion, a PE ratio of 20.57, a price-to-earnings-growth ratio of 1.07 and a beta of 0.11.

Amrize (NYSE:AMRZGet Free Report) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.88 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The company had revenue of $3.50 billion for the quarter. On average, research analysts predict that Amrize will post 2.58 EPS for the current year.

Insider Buying and Selling at Amrize

In other news, insider Stephen S. Clark acquired 5,260 shares of Amrize stock in a transaction that occurred on Tuesday, August 11th. The stock was bought at an average price of $47.31 per share, with a total value of $248,850.60. Following the completion of the purchase, the insider owned 10,637 shares in the company, valued at approximately $503,236.47. The trade was a 97.82% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Mario Gross bought 3,568 shares of the stock in a transaction on Tuesday, August 11th. The stock was purchased at an average price of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the purchase, the insider directly owned 38,485 shares in the company, valued at approximately $1,793,401. This represents a 10.22% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 14,828 shares of company stock worth $697,479 in the last three months. 0.54% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Amrize

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. grew its holdings in shares of Amrize by 5.6% during the fourth quarter. Vanguard Group Inc. now owns 31,770,926 shares of the company’s stock worth $1,722,500,000 after purchasing an additional 1,676,843 shares in the last quarter. Norges Bank purchased a new stake in Amrize in the fourth quarter valued at approximately $929,333,000. Wellington Management Group LLP raised its stake in Amrize by 48.8% in the third quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock valued at $561,018,000 after purchasing an additional 3,809,133 shares in the last quarter. Harris Associates L P bought a new stake in Amrize during the fourth quarter valued at approximately $615,406,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Amrize by 4.6% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,518,018 shares of the company’s stock valued at $459,242,000 after purchasing an additional 420,728 shares during the last quarter.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.